Sweden
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
33.55%
|
Dec. 31, 2023 | USD 0.47 | 0.81% |
|
Sweden |
|
2 |
24.73%
|
Dec. 31, 2023 | USD 18.76 | 3.89% |
|
Sweden |
|
3 |
23.16%
|
Dec. 31, 2023 | USD 0.28 | 0.36% |
|
Sweden |
|
4 |
14.14%
|
Dec. 31, 2023 | USD 19.07 | 4.08% |
|
Sweden |
|
5 |
12.05%
|
Dec. 31, 2023 | USD 16.63 | 0.49% |
|
Sweden |
|
6 |
8.22%
|
Dec. 31, 2023 | USD 3.30 | 3.88% |
|
Sweden |
|
7 |
7.24%
|
Dec. 31, 2023 | USD 0.89 | 14.73% |
|
Sweden |
|
8 |
6.47%
|
Dec. 31, 2023 | USD 12.08 | 1.50% |
|
Sweden |
|
9 |
2.78%
|
Dec. 31, 2023 | USD 0.97 | -2.02% |
|
Sweden |
|
10 |
1.65%
|
Dec. 31, 2023 | USD 0.12 | 3.82% |
|
Sweden |
|
11 |
0.43%
|
Dec. 31, 2023 | USD 2.19 | 0.18% |
|
Sweden |
|
12 |
-20.95%
|
Dec. 31, 2023 | USD 0.15 | 3.82% |
|
Sweden |
|
13 |
-22.21%
|
April 30, 2024 | USD 0.14 | 0.68% |
|
Sweden |
|
14 |
-38.22%
|
Dec. 31, 2023 | USD 1.42 | 3.80% |
|
Sweden |
|
15 |
-102.79%
|
Dec. 31, 2023 | USD 18.25 | 2.79% |
|
Sweden |
|
16 |
-165.73%
|
Dec. 31, 2023 | USD 0.94 | 2.12% |
|
Sweden |
|
17 |
-260.70%
|
Dec. 31, 2023 | USD 0.11 | -0.86% |
|
Sweden |
|
18 |
-381.39%
|
Dec. 31, 2023 | USD 0.56 | 4.18% |
|
Sweden |
|
19 |
-64,454.92%
|
Dec. 31, 2023 | USD 0.19 | 33.40% |
|
Sweden |
The Medical Instruments company in Sweden with the highest EBIT Margin is ContextVision AB (publ) (Oslo Stock Exchange: CONTX.OL) at 33.55%.
The Medical Instruments company in Sweden with the lowest EBIT Margin is Qlife Holding AB (publ) (Stockholm Stock Exchange: QLIFE.ST) at -64,454.92%.
The top 10 Medical Instruments companies in Sweden by EBIT Margin are ContextVision AB (publ), CellaVision AB (publ), ADDvise Group AB (publ), Stille AB, Getinge AB (publ), Arjo AB (publ), Boule Diagnostics AB (publ), AddLife AB (publ), Arcoma AB and Serstech AB.
The bottom 10 Medical Instruments companies in Sweden by EBIT Margin are Qlife Holding AB (publ), Senzime AB (publ), BrainCool AB (publ), AcouSort AB (publ), Vitrolife AB (publ), Sedana Medical AB (publ), ScandiDos AB (publ), Ortivus AB (publ), Mentice AB (publ) and Serstech AB.